Quarterly report pursuant to Section 13 or 15(d)

Schedule of Segment Information (Details)

v3.21.2
Schedule of Segment Information (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Segment Reporting Information [Line Items]          
Revenues, net $ 9,472 $ 3,840 $ 33,885 $ 9,351  
Consolidated cost of revenue 5,495 2,798 16,515 6,615  
Total Depreciation and amortization expense 401 3 1,144 13  
Diagnostic services 13,020 1,608 20,542 4,031  
Total loss from continuing operations, before income taxes (3,978) (569) (4,316) (1,308)  
Income from discontinued operations, before income taxes 161 161  
Net loss (3,978) (408) (4,316) (1,147)  
Total assets 72,630   72,630   $ 31,405
Diagnostic Services [Member]          
Segment Reporting Information [Line Items]          
Revenues, net 7,142 27,416  
Consolidated cost of revenue 4,009 11,833  
Total Depreciation and amortization expense 401 1,138  
Diagnostic services (1,145) 2,859  
Total assets 28,738   28,738   13,410
Consumer Products [Member]          
Segment Reporting Information [Line Items]          
Revenues, net 2,330 3,840 6,469 9,351  
Consolidated cost of revenue 1,486 2,798 4,682 6,615  
Total Depreciation and amortization expense 3 6 13  
Total loss from continuing operations, before income taxes (958) 1,039 (453) 2,723  
Total assets 20,986   20,986   6,261
Unallocated Corporate [Member]          
Segment Reporting Information [Line Items]          
Total loss from continuing operations, before income taxes (1,875) $ (1,608) (6,722) $ (4,031)  
Total assets $ 22,906   $ 22,906   $ 11,734